Literature DB >> 7831416

A new five factor model of schizophrenia.

J P Lindenmayer1, R Bernstein-Hyman, S Grochowski.   

Abstract

Schizophrenic psychopathology is heterogeneous and multidimensional. Various strategies have been developed over the past several years to assess and measure more accurately discrete domains of psychopathology. One of the more fruitful strategies to investigate more homogenous domains of psychopathology has been the positive-negative syndrome approach. However, this approach is unable to address a number of important issues. Most schizophrenics present a mixed syndrome; the criteria for what constitutes a positive and negative syndrome are variable; distinguishing primary from secondary negative symptoms can be difficult. In order to address some of these problems, we propose the introduction of a five syndrome model based on a reanalysis of factor analytic procedures used on 240 schizophrenics assessed with the Positive and Negative Syndrome Scale (PANSS). We present data on a 5-factor solution which appears to best fit the psychopathological data and which is supported by three independent and comparable factor analyses; negative, positive, excitement, cognitive and depression/anxiety domains of psychopathology give patients their individual mark. Data on internal consistency of the five factors and on initial validation using demographic and clinical variables are presented.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7831416     DOI: 10.1007/bf02354306

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  12 in total

Review 1.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

2.  Positive and negative subtypes in acute schizophrenia.

Authors:  J P Lindenmayer; S R Kay; L Opler
Journal:  Compr Psychiatry       Date:  1984 Jul-Aug       Impact factor: 3.735

3.  Deficit and nondeficit forms of schizophrenia: the concept.

Authors:  W T Carpenter; D W Heinrichs; A M Wagman
Journal:  Am J Psychiatry       Date:  1988-05       Impact factor: 18.112

4.  Relations among clinical scales in schizophrenia.

Authors:  R E Gur; P D Mozley; S M Resnick; S Levick; R Erwin; A J Saykin; R C Gur
Journal:  Am J Psychiatry       Date:  1991-04       Impact factor: 18.112

5.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

Authors:  J S Strauss; W T Carpenter; J J Bartko
Journal:  Schizophr Bull       Date:  1974       Impact factor: 9.306

6.  Negative v positive schizophrenia. Definition and validation.

Authors:  N C Andreasen; S Olsen
Journal:  Arch Gen Psychiatry       Date:  1982-07

7.  Pyramidical model of schizophrenia.

Authors:  S R Kay; S Sevy
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

8.  Clozapine effects on positive and negative symptoms: a six-month trial in treatment-refractory schizophrenics.

Authors:  J P Lindenmayer; S Grochowski; L Mabugat
Journal:  J Clin Psychopharmacol       Date:  1994-06       Impact factor: 3.153

9.  Symptomatic and neuropsychological components of defect states.

Authors:  R M Bilder; S Mukherjee; R O Rieder; A K Pandurangi
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

10.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

View more
  50 in total

Review 1.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

Review 2.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

3.  Is disorganization a feature of schizophrenia or a modifying influence: evidence of covariation of perceptual and cognitive organization in a non-patient sample.

Authors:  Keith A Feigenson; Michael A Gara; Matthew W Roché; Steven M Silverstein
Journal:  Psychiatry Res       Date:  2014-03-12       Impact factor: 3.222

4.  Neural Mechanisms Underlying Affective Theory of Mind in Violent Antisocial Personality Disorder and/or Schizophrenia.

Authors:  Boris Schiffer; Christina Pawliczek; Bernhard W Müller; Jens Wiltfang; Martin Brüne; Michael Forsting; Elke R Gizewski; Norbert Leygraf; Sheilagh Hodgins
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

5.  Enhancing and Promoting Recovery In Attentionally Impaired People Diagnosed With Schizophrenia: Results From A Randomized Controlled Trial Of Attention Shaping In A Partial Hospital Program.

Authors:  Steven M Silverstein; Matthew W Roché; Zaynab Khan; Sarah J Carson; Igor Malinovsky; William A Newbill; Anthony A Menditto; Sandra M Wilkniss
Journal:  Am J Psychiatr Rehabil       Date:  2014

6.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

7.  Compromised small-world efficiency of structural brain networks in schizophrenic patients and their unaffected parents.

Authors:  Hao Yan; Lin Tian; Qifeng Wang; Qiang Zhao; Weihua Yue; Jun Yan; Bing Liu; Dai Zhang
Journal:  Neurosci Bull       Date:  2015-03-27       Impact factor: 5.203

8.  Comparison of visual perceptual organization in schizophrenia and body dysmorphic disorder.

Authors:  Steven M Silverstein; Corinna M Elliott; Jamie D Feusner; Brian P Keane; Deepthi Mikkilineni; Natasha Hansen; Andrea Hartmann; Sabine Wilhelm
Journal:  Psychiatry Res       Date:  2015-06-27       Impact factor: 3.222

9.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

10.  Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia.

Authors:  Steven M Silverstein; William D Spaulding; Anthony A Menditto; Adam Savitz; Robert P Liberman; Sarah Berten; Hannah Starobin
Journal:  Schizophr Bull       Date:  2008-01-22       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.